Our computational analysis of the differentially expressed miRNAs and proteins in human AD-MSCs and keratinocytes predicted that miR-155 may potentiate the immunomodulatory effect of AD-MSCs by positively regulating the key proteins FGF2, FGF7, CCL2, and VCAM1. The gene discussed is CCL2; the disease is Alzheimer disease.